Literature DB >> 2178607

Conversion of porcine big endothelin to endothelin by an extract from the porcine aortic endothelial cells.

Y Matsumura1, R Ikegawa, M Takaoka, S Morimoto.   

Abstract

Conversion of porcine big endothelin (big ET) to endothelin (ET) by an extract from cultured porcine aortic endothelial cells was investigated using a radioimmunoassay (RIA) specific for ET and reverse-phase high performance liquid chromatography (RP-HPLC). When big ET was incubated with the extract at an acid pH in the presence of E-64, a cysteine protease inhibitor, the amount of immunoreactive-ET (IR-ET) in the incubation mixture was greatly increased and the optimum pH for this increased reaction was 4.0. The extract-induced increase in IR-ET was completely inhibited by pepstatin-A. These immunoreactive alterations correlated with those in the vasoconstrictor activity. When the incubation mixture of big ET with the cell extract was applied to the RP-HPLC, the IR-ET eluted at the same retention time as seen with synthetic porcine ET. We suggest that a pepstatin-sensitive aspartic protease is involved in the conversion of big ET to ET in vascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178607     DOI: 10.1016/0006-291x(90)91751-d

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Kinetic parameters for the generation of endothelins-1,-2 and -3 by human cathepsin E.

Authors:  P S Robinson; W E Lees; J Kay; N D Cook
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

2.  Mode of cleavage of pig big endothelin-1 by chymotrypsin. Production and degradation of mature endothelin-1.

Authors:  M Takaoka; Y Miyata; Y Takenobu; R Ikegawa; Y Matsumura; S Morimoto
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

3.  Heterologous in vivo processing of human preproendothelin 1 into bioactive peptides.

Authors:  M S Fabbrini; A Vitale; C Patrono; M Zamai; F Vaghi; V Caiolfa; L Monaco; L Benatti
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

4.  Comparison of the cardiovascular and neural activity of endothelin-1, -2, -3 and respective proendothelins: effects of phosphoramidon and thiorphan.

Authors:  G G Mattera; A Eglezos; A R Renzetti; J Mizrahi
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  Metabolism of endothelin-1 and big endothelin-1 by recombinant neutral endopeptidase EC.3.4.24.11.

Authors:  Z A Abassi; E Golomb; R Bridenbaugh; H R Keiser
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

6.  Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin.

Authors:  A C Le Monnier de Gouville; I Cavero
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

7.  Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.

Authors:  K Fujita; Y Matsumura; S Kita; Y Miyazaki; K Hisaki; M Takaoka; S Morimoto
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

8.  Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro.

Authors:  E G McMahon; M A Palomo; W M Moore; J F McDonald; M K Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

Review 9.  New insights into the roles of metalloproteinases in neurodegeneration and neuroprotection.

Authors:  A J Turner; N N Nalivaeva
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.